Dr Rajat Bhattacharya, Senior Consultant, Pediatric Hematology, ACC, Kolkata, said, “The successful implementation of CAR-T cell therapy represents a significant moment in the progress of cancer treatment in India. Treating patients with this revolutionary therapy demonstrates the potential and efficacy of this transformative approach in addressing challenging B-cell malignancies. This milestone marks a new chapter in our fight against cancer, providing new hope and possibilities for those battling these conditions.
Speaking on the occasion, Rana Dasgupta, CEO, Eastern Region, Apollo Hospitals Enterprises Limited, ACC Kolkata, said, “Starting a pioneering journey, Apollo Cancer Centers has achieved a remarkable feat in the field of cancer treatment. “Our commitment to advance CAR-T cell therapy is unwavering. Being the first private hospital in India to achieve success in this transformative therapy sets a new benchmark, reinforcing our dedication to groundbreaking healthcare.”